Skip to content

house · Committee report

H. Rept. 119-114

SUPPORT FOR PATIENTS AND COMMUNITIES REAUTHORIZATION ACT OF 2025

2025-05-29

Committees

Associated legislation

Text

Minority Views

[To accompany H.R. 2483] The Committee on Energy and Commerce, to whom was referred the bill (H.R. 2483) to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes, having considered the same, reports favorably thereon with an amendment and recommends that the bill as amended do pass. CONTENTS Page Purpose and Summary.............................................. 14 Background and Need for Legislation.............................. 15 Committee Action................................................. 16 Committee Votes.................................................. 16 Oversight Findings and Recommendations........................... 18 New Budget Authority, Entitlement Authority, and Tax Expenditures 18 Congressional Budget Office Estimate............................. 18 Federal Mandates Statement....................................... 18 Statement of General Performance Goals and Objectives............ 18 Duplication of Federal Programs.................................. 18 Related Committee and Subcommittee Hearings...................... 18 Committee Cost Estimate.......................................... 19 Earmark, Limited Tax Benefits, and Limited Tariff Benefits....... 19 Advisory Committee Statement..................................... 19 Applicability to Legislative Branch.............................. 19 Section-by-Section Analysis of the Legislation................... 19 Changes in Existing Law Made by the Bill, as Reported............ 24 Minority, Additional, or Dissenting Views........................ 120 Exchange of Letters with Additional Committees of Referral....... 122 The amendment is as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) Short Title.--This Act may be cited as the ``SUPPORT for Patients and Communities Reauthorization Act of 2025''. (b) Table of Contents.--The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. TITLE I--PREVENTION Sec. 101. Prenatal and postnatal health. Sec. 102. Monitoring and education regarding infections associated with illicit drug use and other risk factors. Sec. 103. Preventing overdoses of controlled substances. Sec. 104. Support for individuals and families impacted by fetal alcohol spectrum disorder. Sec. 105. Promoting state choice in PDMP systems. Sec. 106. First responder training program. Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative. Sec. 108. Protecting suicide prevention lifeline from cybersecurity incidents. Sec. 109. Monitoring and reporting of child, youth, and adult trauma. Sec. 110. Bruce's law. Sec. 111. Guidance on at-home drug disposal systems. Sec. 112. Assessment of opioid drugs and actions. Sec. 113. Grant program for State and Tribal response to opioid use disorders. TITLE II--TREATMENT Sec. 201. Residential treatment program for pregnant and postpartum women. Sec. 202. Improving access to addiction medicine providers. Sec. 203. Mental and behavioral health education and training grants. Sec. 204. Loan repayment program for substance use disorder treatment workforce. Sec. 205. Development and dissemination of model training programs for substance use disorder patient records. Sec. 206. Task force on best practices for trauma-informed identification, referral, and support. Sec. 207. Grants to enhance access to substance use disorder treatment. Sec. 208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance. Sec. 209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone. TITLE III--RECOVERY Sec. 301. Building communities of recovery. Sec. 302. Peer support technical assistance center. Sec. 303. Comprehensive opioid recovery centers. Sec. 304. Youth prevention and recovery. Sec. 305. CAREER Act. Sec. 306. Addressing economic and workforce impacts of the opioid crisis. TITLE IV--MISCELLANEOUS MATTERS Sec. 401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner. Sec. 402. Required training for prescribers of controlled substances. TITLE I--PREVENTION SEC. 101. PRENATAL AND POSTNATAL HEALTH. Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b- 13(d)) is amended by striking ``such sums as may be necessary for each of the fiscal years 2019 through 2023'' and inserting ``$4,250,000 for each of fiscal years 2026 through 2030''. SEC. 102. MONITORING AND EDUCATION REGARDING INFECTIONS ASSOCIATED WITH ILLICIT DRUG USE AND OTHER RISK FACTORS. Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b- 15(d)) is amended by striking ``fiscal years 2019 through 2023'' and inserting ``fiscal years 2026 through 2030''. SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES. (a) In General.--Section 392A of the Public Health Service Act (42 U.S.C. 280b-1) is amended-- (1) in subsection (a)(2)-- (A) in subparagraph (C), by inserting ``and associated risks'' before the period at the end; and (B) in subparagraph (D), by striking ``opioids'' and inserting ``substances causing overdose''; and (2) in subsection (b)(2)-- (A) in subparagraph (B), by inserting ``, and associated risk factors,'' after ``such overdoses''; (B) in subparagraph (C), by striking ``coding'' and inserting ``monitoring and identifying''; (C) in subparagraph (E)-- (i) by inserting a comma after ``public health laboratories''; and (ii) by inserting ``and other emerging substances related'' after ``analogues''; and (D) in subparagraph (F), by inserting ``and associated risk factors'' after ``overdoses''. (b) Additional Grants.--Section 392A(a)(3) of the Public Health Service Act (42 U.S.C. 280b-1(a)(3)) is amended-- (1) in the matter preceding subparagraph (A), by striking ``and Indian Tribes--'' and inserting ``and Indian Tribes for the following purposes:''; (2) by amending subparagraph (A) to read as follows: ``(A) To carry out innovative projects for grantees to detect, identify, and rapidly respond to controlled substance misuse, abuse, and overdoses, and associated risk factors, including changes in patterns of such controlled substance use. Such projects may include the use of innovative, evidence-based strategies for detecting such patterns, such as wastewater surveillance, if proven to support actionable prevention strategies, in a manner consistent with applicable Federal and State privacy laws.''; and (3) in subparagraph (B), by striking ``for any'' and inserting ``For any''. (c) Authorization of Appropriations.--Section 392A(e) of the Public Health Service Act (42 U.S.C. 280b-1(e)) is amended by striking ``$496,000,000 for each of fiscal years 2019 through 2023'' and inserting ``$505,579,000 for each of fiscal years 2026 through 2030''. SEC. 104. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL ALCOHOL SPECTRUM DISORDER. (a) In General.--Part O of title III of the Public Health Service Act (42 U.S.C. 280f et seq.) is amended to read as follows: ``PART O--FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES PROGRAM ``SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, INTERVENTION, AND SERVICES DELIVERY PROGRAM. ``(a) In General.--The Secretary shall establish or continue activities to support a comprehensive fetal alcohol spectrum disorders (referred to in this section as `FASD') education, prevention, identification, intervention, and services delivery program, which may include-- ``(1) an education and public awareness program to support, conduct, and evaluate the effectiveness of-- ``(A) educational programs targeting health professions schools, social and other supportive services, educators and counselors and other service providers in all phases of childhood development, and other relevant service providers, concerning the prevention, identification, and provision of services for infants, children, adolescents, and adults with FASD; ``(B) strategies to educate school-age children, including pregnant and high-risk youth, concerning FASD; ``(C) public and community awareness programs concerning FASD; and ``(D) strategies to coordinate information and services across affected community agencies, including agencies providing social services such as foster care, adoption, and social work, agencies providing health services, and agencies involved in education, vocational training, and civil and criminal justice; ``(2) supporting and conducting research on FASD, as appropriate, including to-- ``(A) develop appropriate medical diagnostic methods for identifying FASD; and ``(B) develop effective culturally and linguistically appropriate evidence-based or evidence-informed interventions and appropriate supports for preventing prenatal alcohol exposure, which may co-occur with exposure to other substances; ``(3) building State and Tribal capacity for the identification, treatment, and support of individuals with FASD and their families, which may include-- ``(A) utilizing and adapting existing Federal, State, or Tribal programs to include FASD identification and FASD-informed support; ``(B) developing and expanding screening and diagnostic capacity for FASD; ``(C) developing, implementing, and evaluating targeted FASD-informed intervention programs for FASD; ``(D) providing training with respect to FASD for professionals across relevant sectors; and ``(E) disseminating information about FASD and support services to affected individuals and their families; and ``(4) an applied research program concerning intervention and prevention to support and conduct service demonstration projects, clinical studies and other research models providing advocacy, educational and vocational training, counseling, medical and mental health, and other supportive services, as well as models that integrate and coordinate such services, that are aimed at the unique challenges facing individuals with fetal alcohol spectrum disorder or fetal alcohol effect and their families. ``(b) Grants and Technical Assistance.-- ``(1) In general.--The Secretary may award grants, cooperative agreements and contracts and provide technical assistance to eligible entities to carry out subsection (a). ``(2) Eligible entities.--To be eligible to receive a grant, or enter into a cooperative agreement or contract, under this section, an entity shall-- ``(A) be a State, Indian Tribe or Tribal organization, local government, scientific or academic institution, or nonprofit organization; and ``(B) prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a description of the activities that the entity intends to carry out using amounts received under this section. ``(3) Additional application contents.--The Secretary may require that an eligible entity include in the application submitted under paragraph (2)(B)-- ``(A) a designation of an individual to serve as a FASD State or Tribal coordinator of activities such eligible entity proposes to carry out through a grant, cooperative agreement, or contract under this section; and ``(B) a description of an advisory committee the entity will establish to provide guidance for the entity on developing and implementing a statewide or Tribal strategic plan to prevent FASD and provide for the identification, treatment, and support of individuals with FASD and their families. ``(c) Definition of FASD-Informed.--For purposes of this section, the term `FASD-informed', with respect to support or an intervention program, means that such support or intervention program uses culturally and linguistically informed evidence-based or practice-based interventions and appropriate resources to support an improved quality of life for an individual with FASD and the family of such individual. ``SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION FOR FETAL ALCOHOL SPECTRUM DISORDERS. ``(a) In General.--The Secretary shall award grants, contracts, or cooperative agreements, as the Secretary determines appropriate, to public or nonprofit private entities with demonstrated expertise in the field of fetal alcohol spectrum disorders (referred to in this section as `FASD'). Such awards shall be for the purposes of building local, Tribal, State, and nationwide capacities to prevent the occurrence of FASD by carrying out the programs described in subsection (b). ``(b) Programs.--An entity receiving an award under subsection (a) may use such award for the following purposes: ``(1) Developing and supporting public education and outreach activities to raise public awareness of the risks associated with alcohol consumption during pregnancy. ``(2) Acting as a clearinghouse for evidence-based resources on FASD prevention, identification, and culturally and linguistically appropriate best practices to help inform systems of care for individuals with FASD across their lifespan. ``(3) Increasing awareness and understanding of efficacious, evidence-based screening tools and culturally and linguistically appropriate evidence-based intervention services and best practices, which may include improving the capacity for State, Tribal, and local affiliates. ``(4) Providing technical assistance to recipients of grants, cooperative agreements, or contracts under section 399H, as appropriate. ``(c) Application.--To be eligible for a grant, contract, or cooperative agreement under this section, an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. ``(d) Subcontracting.--A public or private nonprofit entity may carry out the following activities required under this section through contracts or cooperative agreements with other public and private nonprofit entities with demonstrated expertise in FASD: ``(1) Resource development and dissemination. ``(2) Intervention services. ``(3) Training and technical assistance. ``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS. ``There are authorized to be appropriated to carry out this part $12,500,000 for each of fiscal years 2026 through 2030.''. (b) Report.--Not later than 4 years after the date of enactment of this Act, and every year thereafter, the Secretary of Health and Human Services shall prepare and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report containing-- (1) a review of the activities carried out pursuant to sections 399H and 399I of the Public Health Service Act, as amended, to advance public education and awareness of fetal alcohol spectrum disorders (referred to in this section as ``FASD''); (2) a description of-- (A) the activities carried out pursuant to such sections 399H and 399I to identify, prevent, and treat FASD; and (B) methods used to evaluate the outcomes of such activities; and (3) an assessment of activities carried out pursuant to such sections 399H and 399I to support individuals with FASD. SEC. 105. PROMOTING STATE CHOICE IN PDMP SYSTEMS. Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g- 3(h)) is amended by adding at the end the following: ``(5) Promoting state choice.--Nothing in this section shall be construed to authorize the Secretary to require States to use a specific vendor or a specific interoperability connection other than to align with nationally recognized, consensus-based open standards, such as in accordance with sections 3001 and 3004.''. SEC. 106. FIRST RESPONDER TRAINING PROGRAM. Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is amended-- (1) in subsection (a), by striking ``tribes and tribal'' and inserting ``Tribes and Tribal''; (2) in subsections (a), (c), and (d)-- (A) by striking ``approved or cleared'' each place it appears and inserting ``approved, cleared, or otherwise legally marketed''; and (B) by striking ``opioid'' each place it appears; (3) in subsection (f)-- (A) by striking ``approved or cleared'' each place it appears and inserting ``approved, cleared, or otherwise legally marketed''; (B) in paragraph (1), by striking ``opioid''; (C) in paragraph (2)-- (i) by striking ``opioid and heroin'' and inserting ``opioid, heroin, and other drug''; and (ii) by striking ``opioid overdose'' and inserting ``overdose''; and (D) in paragraph (3), by striking ``opioid and heroin''; and (4) in subsection (h), by striking ``$36,000,000 for each of fiscal years 2019 thro

Purpose and Summary

The bill reauthorizes key public health programs that help prevent drug overdoses, provide access to treatment for those in need, and support opportunities for those recovering from substance use disorder.

Background and Need for Legislation

The United States is currently facing an overdose crisis. Substance addiction, abuse, and misuse remain a major public health issue. Over 107,000 Americans lost their lives to a drug overdose in 2023.\1\ In addition, 40 to 60 percent of individuals treated for substance use disorders will relapse at least once.\2\ Lastly, over 93 percent of people with a past- year substance use disorder (SUD) did not receive specialty treatment.\3\ --------------------------------------------------------------------------- \1\U.S. Drug Enforcement Administration (DEA), DEA Releases 2024 National Drug Threat Assessment, (May 2024), https://www.dea.gov/press- releases/2024/05/09/dea-releases-2024-national-drug-threat-assessment. \2\Maria Sugue, 2025 Addiction Statistics: Accurate Data on Substance Abuse in the US, Addiction Group (Feb. 17, 2025), https:// www.addictiongroup.org/resources/addiction-statistics/. \3\Id. --------------------------------------------------------------------------- Congress took action to address the crisis in 2016 with the passage of the Comprehensive Addiction and Recovery Act and the 21st Century Cares Act, which established new funding for prevention, treatment, and recovery services for people struggling with substance use disorder. The two laws attempted to address a growing prescription opioid epidemic that, at the time, was killing as many as 50,000 to 60,000 Americans per year.\4\ However, as overdose deaths rose to nearly 70,000 deaths per year, Congress took further action in 2018 to tackle the evolving crisis by passing the Substance Use-Disorder Prevention That Promotes Opioid Recovery And Treatment For Patients And Communities Act (or SUPPORT Act).\5\ The SUPPORT Act was the largest investment in overdose prevention programs by funding efforts to improve care, including efforts to reduce barriers to all levels of the care continuum and allocate resources to states and providers for the purposes of preventing and treating substance use disorder. --------------------------------------------------------------------------- \4\U.S. Centers for Disease Control and Prevention (CDC), Drug Overdose Deaths in the United States, 1999-2016, National Center for Health Statistics (Dec. 2017), https://www.cdc.gov/nchs/data/ databriefs/db356-h.pdf. \5\CDC, Drug Overdose Deaths in the United States, 1999-2018, National Center for Health Statistics (Jan. 2020), https://www.cdc.gov/ nchs/data/databriefs/db356-h.pdf. --------------------------------------------------------------------------- Congress' work proved to be initially successful, evidenced by annual overdose deaths decreasing for the first time since 2018.\6\ However, the current landscape has changed since 2018. Fentanyl is now the primary driver of overdoses in the United States, accounting for 70 percent of all overdose deaths.\7\ Further, the country is grappling with a mental health crisis, fueled by the COVID-19 pandemic, which has driven millions of new Americans to use and misuse drugs for the first time and set back countless others on their road to recovery.\8\ --------------------------------------------------------------------------- \6\CDC, U.S. Overdose Deaths Decrease in 2023, First Time since 2018, National Center for Health Statistics (May 2024), https:// www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm. \7\DEA, DEA Releases 2024 National Drug Threat Assessment, (May 2024), https://www.dea.gov/press-releases/2024/05/09/dea-releases-2024- national-drug-threat-assessment. \8\CDC, Overdose Deaths Accelerating During COVID-19, CDC Archive (Dec. 2020), https:// archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2020/ p1218-overdose-deaths-covid-19.html. --------------------------------------------------------------------------- Key provisions from the SUPPORT Act expired in 2023. The SUPPORT for Patients and Communities Reauthorization Act of 2025 would advance SUD treatment for patients and allocate resources to strengthen the addiction treatment and workforce.

Committee Action

On June 9, 2023, the Subcommittee on Health held a field hearing in Gettysburg, Pennsylvania, on issues related to substance use disorder.\9\ The title of the hearing was ``Addressing the Opioid Crisis: Examining the SUPPORT Act Five Years Later.'' The Subcommittee received testimony from: --------------------------------------------------------------------------- \9\During the 118th Congress, this hearing was used to develop H.R. 4531. --------------------------------------------------------------------------- Emily Keller, Special Secretary of Opioid Response, Opioid Operational Command Center, Office of Governor Wes Moore; Mike Straley, Founder, Leah's Legacy Foundation; Mitchell Crawford, DO, Medical Director, Specialized Treatment and Recovery, WellSpan Health, Director, Addiction Services, WellSpan Health; and William Ceravola, Reading Township Police Department. On June 21, 2023, the Subcommittee on Health held a hearing on H.R. 4531.\10\ The title of the hearing was ``Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act.'' The Subcommittee received testimony from: --------------------------------------------------------------------------- \10\Provisions of H.R. 4531 were reintroduced in the 119th Congress as H.R. 2483. --------------------------------------------------------------------------- Matthew Strait, Deputy Assistant Administrator, Office of Diversion Control for the Drug Enforcement Administration; Christopher Jones, Director of the National Center for Injury Prevention and Control for the Centers for Disease Control and Prevention; Diana Espinosa, Principal Deputy Administrator of the Health Resources and Services Administration, Acting Deputy Assistant Secretary for Mental Health and Substance Use; Tom Coderre, Acting Deputy Assistant Secretary for Mental Health and Substance Use; and Jonathan Blum, Principal Deputy Administrator and Chief Operating Officer for the Centers for Medicare and Medicaid Services. On July 13, 2023, the Subcommittee on Health met in open markup session and forwarded H.R. 4531, without amendment, to the full Committee by a voice vote. On July 19, 2023, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 4531, as amended, favorably reported to the House by a record vote of 48 yeas and 0 nays. On April 29, 2025, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 2483, as amended, favorably reported to the House by a record vote of 36 yeas and 13 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held hearings and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 2483 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.

Congressional Budget Office Estimate

Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 2483 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearings were used to develop or consider H.R. 2483: On June 9, 2023, the Subcommittee on Health held a field hearing in Gettysburg, Pennsylvania, on issues related to substance use disorder.\11\ The title of the hearing was ``Addressing the Opioid Crisis: Examining the SUPPORT Act Five Years Later.'' The Subcommittee received testimony from: --------------------------------------------------------------------------- \11\During the 118th Congress, this hearing was used to develop H.R. 4531. --------------------------------------------------------------------------- Emily Keller, Special Secretary of Opioid Response, Opioid Operational Command Center, Office of Governor Wes Moore; Mike Straley, Founder, Leah's Legacy Foundation; Mitchell Crawford, DO, Medical Director, Specialized Treatment and Recovery, WellSpan Health, Director, Addiction Services, WellSpan Health; and William Ceravola, Reading Township Police Department. On June 21, 2023, the Subcommittee on Health held a hearing on H.R. 4531. The title of the hearing was ``Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act.'' Subcommittee received testimony from: Matthew Strait, Deputy Assistant Administrator, Office of Diversion Control for the Drug Enforcement Administration; Christopher Jones, Director of the National Center for Injury Prevention and Control for the Centers for Disease Control and Prevention; Diana Espinosa, Principal Deputy Administrator of the Health Resources and Services Administration, Acting Deputy Assistant Secretary for Mental Health and Substance Use; Tom Coderre, Acting Deputy Assistant Secretary for Mental Health and Substance Use; and Jonathan Blum, Principal Deputy Administrator and Chief Operating Officer for the Centers for Medicare and Medicaid Services. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 2483 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 1. Short title; table of contents Section 1 provides that the Act may be cited as the ``SUPPORT for Patients and Communities Reauthorization Act of 2025.'' In addition, this section also provides a table of contents for the Act. TITLE I--PREVENTION Section 101. Prenatal and postnatal health This section reauthorizes section 317L of the Public Health Service Act for fiscal year (FY) 2026 through FY 2030 to continue activities to address neonatal abstinence syndrome and prenatal substance use and misuse, as well as to continue efforts to understand the outcomes of treating opioid use disorder during pregnancy. Section 102. Monitoring and education regarding infections associated with illicit drug use and other risk factors This section reauthorizes section 317N of the Public Health Service Act for FY 2026 through FY 2030 to continue efforts to prevent and respond to infections commonly associated with illicit drug use. Section 103. Preventing overdoses of controlled substances This section reauthorizes section 392A of the Public Health Service Act for FY 2026 through FY 2030 to continue support for State efforts to enhance overdose data collection and improve prescription drug monitoring programs (PDMP). Section 104. Support for individuals and families impacted by fetal alcohol spectrum disorder This section reauthorizes federal fetal alcohol spectrum disorder programs under the Department of Health and Human Services (HHS) that support prevention, education, intervention, and research for FY 2026 through FY 2030. Section 105. Promoting state choice in PDMP systems This section clarifies that HHS cannot require states to use a specific vendor or interoperability connection in PDMP systems. Section 106. First responder training This section reauthorizes section 546 of the Public Health Service Act for FY 2026 through FY 2030. This program helps support first responders and members of other key community sectors to administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose. Section 107. Donald J. Cohen National Child Traumatic Stress Initiative This section reauthorizes section 582 of the Public Health Service Act for FY 2026 through FY 2030. This program supports training initiatives focused on mental, behavioral, and biological aspects of psychological trauma response, prevention of long-term consequences of child trauma, and early intervention services to address long-term impacts of child trauma. Section 108. Protecting suicide prevention lifeline from cybersecurity incidents This section requires internal coordination within HHS and improved reporting mechanisms to protect the 9-8-8 Suicide & Crisis Lifeline from cybersecurity incidents. This also requires a study and report to Congress of any cybersecurity vulnerabilities associated with the Lifeline. Section 109. Monitoring and reporting of child, youth, and adult trauma This section reauthorizes section 7131(e) of the SUPPORT for Patients and Communities Act for FY 2026 through FY 2030 to continue efforts to collect and report information on adverse childhood experiences. Section 110. Bruce's law This section allows HHS to develop a public education and awareness campaign focused on drug overdose prevention, detection of early warning signs of addiction among youth, and dangers of drugs that could be contaminated with fentanyl. In addition, this section allows the Secretary of HHS to begin a Federal Interagency Working Group on Fentanyl Contamination of Illegal Drugs. Section 111. Guidance on at-home drug disposal systems This section directs the Food and Drug Administration (FDA), in consultation with the Drug Enforcement Administration (DEA), to issue guidance to facilitate the use of at-home safe disposal systems. Such guidance shall include recommended standards to meet relevant requirements, recommended instructions for use both at-home and for licensed health providers disseminating information, as well as best practices and educational tools to support effective use of such systems. Section 112. Assessment of opioid drugs and actions This section requires the Secretary of HHS to publish a report outlining a plan for assessing approved opioid analgesic drugs that addresses the public health effects of these drugs as part of a benefit-risk assessment, as well as an update on FDA's activities related to developing nonaddictive medical products. This section requires that HHS provide an opportunity for public input regarding FDA's regulation of opioid analgesic drugs. Section 113. Grant program for State and Tribal response to opioid use disorders This section clarifies that the Substance Abuse and Mental Health Services Administration's (SAMHSA's) State and Tribal opioid response grants may be used for fentanyl or xylazine test strips in States where they are legal. TITLE II--TREATMENT Section 201. Residential treatment program for pregnant and postpartum women This section reauthorizes section 508 of the Public Health Service Act for FY 2026 through FY 2030. This program helps support residential treatment recovery services for pregnant and postpartum women with substance use disorder. Section 202. Improving access to addiction medicine providers This section adds addiction medicine specialists to the eligible entities under the Fellowship Program. Section 203. Mental and behavioral health education and training grants This section reauthorizes section 756 of the Public Health Service Act for FY 2026 through FY 2030. This program helps recruit and educate students to pursue careers in the fields of behavioral and mental health, including substance use disorder treatment. Section 204. Loan repayment program for substance use disorder treatment workforce This section reauthorizes section 781 of the Public Health Service Act for FY 2026 through FY 2030. This program, known as the ``STAR Loan Repayment Program,'' helps recruit and retain substance use disorder professionals. Section 205. Development and dissemination of model training programs for substance use disorder patient records This section strikes the authorization of appropriations for Section 7053 of the SUPPORT for Patients and Communities Act. Section 206. Task force on best practices for trauma-informed identification, referral, and support This section extends the authority for section 7132 of the SUPPORT Act, known as the Interagency Task Force on Trauma- Informed Care, to identify, evaluate, and make recommendations on best practices with respect to children and youth who may experience trauma, through 2030. Section 207. Grants to enhance access to substance use disorder treatment This section strikes the authorization of appropriations for Section 3203 of the SUPPORT for Patients and Communities Act. Section 208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance This section requires SAMHSA to review State uses of funding for activities to identify and address early serious mental illness and children with a serious emotional disturbance under the Community Mental Health Services Block Grant program. This also requires the Secretary to publish a report to Congress and update related guidance to States based on its findings to improve the quality of care provided through Block Grant funds. Section 209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone This section requires HHS and DEA to review the scheduling of buprenorphine-naloxone combination products under the Controlled Substances Act. TITLE III--RECOVERY Section 301. Building communities of recovery This section reauthorizes section 547 of the Public Health Service Act for FY 2026 through FY 2030. This program helps support recovery community organizations to develop, expand, and enhance recovery services. Section 302. Peer support technical assistance center This section reauthorizes the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support, which supports recovery community organizations and peer support networks that provide substance use disorder peer support services. Additionally, this allows for a regional approach to providing this technical assistance. Section 303. Comprehensive opioid recovery centers This section reauthorizes section 552 of the Public Health Service Act for FY 2026 through FY 2030. This program supports the operation of comprehensive opioid recovery centers that provide a full spectrum of treatment and recovery support services for individuals with substance use disorder. Section 304. Youth prevention and recovery This section reauthorizes section 7102 of the SUPPORT Act for FY 2026 through FY 2030. This program provides support for prevention, treatment, and recovery for children, adolescents, and young adults suffering from substance use disorder. Section 305. CAREER Act This section reauthorizes Section 7183 and 8071 of the SUPPORT Act for FY 2026 through FY 2030. This program provides grants for substance use disorder treatment programs that help individuals in recovery re-enter the workforce, including support for recovery housing. Section 306. Addressing economic and workforce impacts of the opioid crisis This section reauthorizes section 8041 of the SUPPORT Act for FY 2026 through FY 2030 to continue resources to address various economic impacts associated with a high rate of substance use disorder in a given area. TITLE IV--MISCELLANEOUS MATTERS Section 401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner This section clarifies that pharmacies may deliver a Schedule III, IV, or V controlled substance to an administering practitioner, with post administration monitoring requirements, in lieu of delivering such substances to the ultimate user. Section 402. Required training for prescribers of controlled substances This section makes technical changes to training requirements for prescribers of opioids by including additional professional societies and accrediting bodies. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): PUBLIC HEALTH SERVICE ACT * * * * * * * TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE * * * * * * * Part B--Federal-State Cooperation * * * * * * * prenatal and postnatal health Sec. 317L. (a) In General.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out programs-- (1) to collect, analyze, and make available data on prenatal smoking and alcohol and other substance abuse and misuse, including-- (A) data on-- (i) the incidence, prevalence, and implications of such activities; and (ii) the incidence and prevalence of implications and outcomes, including neonatal abstinence syndrome and other maternal and child health outcomes associated with such activities; and (B) additional information or data, as appropriate, on family health history, medication exposures during pregnancy, demographic information, such as race, ethnicity, geographic location, and family history, and other relevant information, to inform such analysis; (2) to conduct applied epidemiological research on the prevention and long-term outcomes associated with prenatal and postnatal smoking, alcohol and other substance abuse and misuse; (3) to support, conduct, and evaluate the effectiveness of educational, treatment, and cessation programs; (4) to provide information and education to the public on the prevention and implications of prenatal and postnatal smoking, alcohol and other substance abuse and misuse; and (5) to issue public reports on the analysis of data described in paragraph (1), including analysis of-- (A) long-term outcomes of children affected by neonatal abstinence syndrome; (B) health outcomes associated with prenatal smoking, alcohol, and substance abuse and misuse; and (C) relevant studies, evaluations, or information the Secretary determines to be appropriate. (b) Grants.--In carrying out subsection (a), the Secretary may award grants to and enter into contracts with States, local governments, tribal entities, scientific and academic institutions, federally qualified health centers, and other public and nonprofit entities, and may provide technical and consultative assistance to such entities. (c) Coordinating Activities.--To carry out this section, the Secretary may-- (1) provide technical and consultative assistance to entities receiving grants under subsection (b); (2) ensure a pathway for data sharing between States, tribal entities, and the Centers for Disease Control and Prevention; (3) ensure data collection under this section is consistent with applicable State, Federal, and Tribal privacy laws; and (4) coordinate with the National Coordinator for Health Information Technology, as appropriate, to assist States and Tribes in implementing systems that use standards recognized by such National Coordinator, as such recognized standards are available, in order to facilitate interoperability between such systems and health information technology systems, including certified h

Minority Views

H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025, reauthorizes public health programs that help address the ongoing opioid epidemic. This historically bipartisan bill should have continued to earn bipartisan support, but Congressional Republicans have refused to conduct proper oversight of the Trump Administration's dismantling of the Substance Abuse and Mental Health Services Administration (SAMHSA), the agency responsible for the United States' response to ongoing mental health and substance use disorder crises and for carrying out many of the programs reauthorized by H.R. 2483. On February 14, 2025, the Trump Administration fired approximately 100 probationary employees at SAMHSA.\1\ This was more than 10 percent of the agency's workforce.\2\ On April 1, 2025, there was another round of mass firing at the agency as part of a department-wide Reduction in Force (RIF), including senior officials such as the Director of the Center for Mental Health Services and the Director of the Center for Substance Use Treatment.\3\ The Administration has refused to answer written questions regarding exactly how many people were fired, despite repeated requests from the Ranking Member and Minority Committee staff. However, reports indicate that up 50 percent of the agency's staff have been fired.\4\ --------------------------------------------------------------------------- \1\`Deliberate Trauma': SAMHSA Employees Detail a Federal Agency in Shambles, STAT (Mar. 12, 2025). \2\Department of Health and Human Services, Fiscal Year 2025 Substance Use and Mental Health Services Administration Justification of Estimates for Appropriations Committees. (https://www.samhsa.gov/ sites/default/files/samhsa-fy-2025-cj.pdf) (accessed Apr. 30, 2025). \3\SAMHSA Firings Continue, Devastating U.S. Mental Health Agency, MindSite News (Apr. 1, 2025). \4\As SAMHSA Cuts Loom, Behavioral Health Orgs Fight to Protect Funding, Filter (Apr. 17, 2025). --------------------------------------------------------------------------- In March, the Trump Administration also revealed plans to eliminate SAMHSA altogether and combine mental health and substance use programs with unrelated programs such as occupational health and safety and toxic substances in a new ``Administration for a Healthy America.''\5\ This action will deprioritize mental health and substance use efforts within the federal government, and it has been opposed by dozens of leading mental health and substance use groups.\6\ --------------------------------------------------------------------------- \5\Department of Health and Human Services, HHS Announces Transformation to Make America Healthy Again (Mar. 27, 2025) (press release). \6\Legal Action Center, Joint Statement Opposing SAMHSA Cuts and Any Harmful HHS Restructuring (Apr. 15, 2025) (press release). --------------------------------------------------------------------------- At the same time, the Trump Administration illegally rescinded over $1 billion from state and local behavioral health programs under Mental Health and Substance Use Block Grant funding.\7\ These funds were appropriated by the American Rescue Plan Act during the COVID-19 pandemic, but the funding was never limited to be used only for COVID-19 activities or during a public health emergency. The funding was already obligated to states and rescinding it has only undermined States' ability to address the overdose crisis. --------------------------------------------------------------------------- \7\Trump Administration Abruptly Cuts Billions From State Health Services, The New York Times (Mar. 26, 2025). --------------------------------------------------------------------------- On April 16, 2025, an internal budget document revealed the Trump Administration's plans for drastic cuts across the Department of Health and Human Services (HHS).\8\ The document listed out specific programs that are poised to be eliminated, including 40 different mental health and substance use programs. Among these programs were eight programs reauthorized by H.R. 2483, including programs that train first responders for overdose response, provide residential treatment for pregnant and postpartum women, a task force on best practices for trauma-informed care, support the full spectrum of recovery services, target youth substance use disorder prevention, and help individuals in recovery reenter the workforce.\9\ --------------------------------------------------------------------------- \8\Internal Budget Document Reveals Extent of Trump's Proposed Health Cuts, The Washington Post (Apr. 16, 2025). \9\The Leaked OMB Passback Document: What It Is and Isn't, McDermott+ (Apr. 24, 2025). --------------------------------------------------------------------------- Congressional Republicans have stood silently by while the Trump Administration decimates our mental health and substance use prevention, treatment, and recovery landscape. It is Congress' job to ensure that agencies can continue their critical work and that authorized programs are not arbitrarily and illegally slashed. Without proper Congressional oversight, there is little evidence to inspire confidence that H.R. 2438 will be faithfully implemented, or that we can make meaningful progress to combat the opioid crisis or improve the mental health and well being of all Americans. Frank Pallone, Jr., Ranking Member. [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] [all]

Source: https://api.congress.gov/v3/committee-report/119/hrpt/114